Omar Alkasabrah, MD

1.1K posts

Omar Alkasabrah, MD

Omar Alkasabrah, MD

@alkasabrah

MD | JUST graduate | IM resident @ NYMC/LMC 🇺🇸 🇦🇪 🇯🇴

RI, USA / Abu Dhabi, UAE Katılım Temmuz 2014
690 Takip Edilen394 Takipçiler
Omar Alkasabrah, MD
Omar Alkasabrah, MD@alkasabrah·
Honored to be part of this great project comparing key therapies for UC in patients with prior anti-TNF exposure. Congratulations to the entire team, and special credit to my friend @Eldesouki_mo for his leadership, dedication, and tremendous effort in leading this work.
Mohamed Eldesouki, MD@Eldesouki_mo

👉🏼 Our study at @JCGjournal demonstrates higher effectiveness of upadacitinib compared with ustekinumab in UC patients with prior anti-TNF exposure 📊, with lower 1-year corticosteroid use observed in the upadacitinib group (40.1% vs 48.5%) 💊 📚 journals.lww.com/jcge/abstract/… @TandonKp @ElfertKhaled @MouhandMD @alkasabrah

English
0
0
5
1.1K
Omar Alkasabrah, MD retweetledi
Mohamed Eldesouki, MD
Mohamed Eldesouki, MD@Eldesouki_mo·
‼️ New Publication ‼️ Excited to share our latest systematic review in @FrontImmunol exploring how mechanical forces shape macrophage behavior across the GI tract, liver, and other organs. We highlight how tissue stiffness and mechanosensing pathways drive inflammation, fibrosis, and progression of chronic liver disease. 📖 Read the full article: frontiersin.org/journals/immun… Grateful for the mentorship and support from @BeyderLab and #Gianluca_Cipriani 🙏
Mohamed Eldesouki, MD tweet media
English
2
3
18
1.1K
Omar Alkasabrah, MD
Omar Alkasabrah, MD@alkasabrah·
The X account for my friend mohamed Eldesouki got hacked. Please avoid opening any links and watch out for any scams
English
0
0
0
144
Omar Alkasabrah, MD retweetledi
Mohamed Eldesouki, MD
Mohamed Eldesouki, MD@Eldesouki_mo·
📢 New publication in Alimentary Pharmacology & Therapeutics @APandT Gastroparesis appears to be a frequent complication after thoracic transplantation. 🫁 Lung ± Heart–Lung Transplant 📊 21 studies | 2,888 patients Key findings: 🔹 Prevalence: 31.9% 🔹 Incidence: 25.7% 🔹 Higher rates observed in heart–lung transplant recipients 💡 Early recognition and monitoring may improve outcomes in this vulnerable population. Grateful to my coauthors and Dr Sharma @AmolSharmaMD for the continued support! doi.org/10.1111/apt.70…
Mohamed Eldesouki, MD tweet media
English
1
2
22
1.7K
Omar Alkasabrah, MD
Omar Alkasabrah, MD@alkasabrah·
@ElfertKhaled Unfortunately, I know applicants with strong credentials who didn’t match neurology this year. This is really surprising
English
0
0
1
115
Khaled Elfert
Khaled Elfert@ElfertKhaled·
Neurology data are the most surprising to me
Dr Ahmad Rehan Khan@AhmadRehanKhan

This data shows the PGY-1 Match rates for 2025 vs. 2026 based on the provided NRMP tables. ​1. Internal Medicine (Categorical): ​U.S. MD Seniors: 83.6% (2025) → 84.2% (2026) — Slightly Easier ​U.S. DO Seniors: 78.5% (2025) → 78.7% (2026) — Stable ​U.S. IMGs: 54.5% (2025) → 56.8% (2026) — Easier ​Non-U.S. IMGs: 46.8% (2025) → 44.4% (2026) — Harder ​2. Family Medicine: ​U.S. MD Seniors: 86.3% (2025) → 85.2% (2026) — Slightly Harder ​U.S. DO Seniors: 77.7% (2025) → 79.5% (2026) — Easier ​U.S. IMGs: 49.0% (2025) → 48.5% (2026) — Stable ​Non-U.S. IMGs: 37.7% (2025) → 34.3% (2026) — Harder ​3. Pediatrics (Categorical): ​U.S. MD Seniors: 88.1% (2025) → 87.4% (2026) — Stable ​U.S. DO Seniors: 89.3% (2025) → 89.4% (2026) — Stable ​U.S. IMGs: 66.8% (2025) → 64.7% (2026) — Slightly Harder ​Non-U.S. IMGs: 50.3% (2025) → 46.2% (2026) — Harder ​4. Psychiatry: ​U.S. MD Seniors: 84.0% (2025) → 88.2% (2026) — Easier ​U.S. DO Seniors: 78.1% (2025) → 83.4% (2026) — Easier ​U.S. IMGs: 46.5% (2025) → 54.8% (2026) — Significantly Easier ​Non-U.S. IMGs: 46.5% (2025) → 51.9% (2026) — Easier ​5. Neurology: ​U.S. MD Seniors: 68.2% (2025) → 71.1% (2026) — Easier ​U.S. DO Seniors: 62.3% (2025) → 62.6% (2026) — Stable ​U.S. IMGs: 34.1% (2025) → 36.0% (2026) — Stable ​Non-U.S. IMGs: 35.6% (2025) → 26.3% (2026) — Much Harder ​6. Pathology: ​U.S. MD Seniors: 89.2% (2025) → 87.1% (2026) — Slightly Harder ​U.S. DO Seniors: 80.0% (2025) → 73.0% (2026) — Harder ​U.S. IMGs: 41.9% (2025) → 46.7% (2026) — Easier ​Non-U.S. IMGs: 41.5% (2025) → 42.4% (2026) — Stable ​7. Surgery (Categorical): ​U.S. MD Seniors: 74.5% (2025) → 70.3% (2026) — Harder ​U.S. DO Seniors: 58.7% (2025) → 60.3% (2026) — Slightly Easier ​U.S. IMGs: 29.2% (2025) → 25.0% (2026) — Harder ​Non-U.S. IMGs: 21.4% (2025) → 23.1% (2026) — Slightly Easier ​8. Obstetrics-Gynecology: ​U.S. MD Seniors: 84.7% (2025) → 85.6% (2026) — Stable ​U.S. DO Seniors: 66.5% (2025) → 67.8% (2026) — Slightly Easier ​U.S. IMGs: 38.8% (2025) → 34.9% (2026) — Harder ​Non-U.S. IMGs: 34.6% (2025) → 29.6% (2026) — Harder. ​Summary Trend Analysis: ​The Psychiatry "Boom": All groups saw a rise in success rates, particularly U.S. IMGs who saw a nearly +9% jump. ​The Neurology Divergence: While U.S. MD seniors found it easier to match this year, Non-U.S. IMGs faced a brutal -9.3% drop in their match rate. ​Surgery Realities: This continues to be the most gatekept specialty for IMGs, with match rates consistently hovering between 20-25%. ​DO Growth: U.S. DO Seniors have essentially closed the gap with MD seniors in Family Medicine and Pediatrics. Data Courtesy: @NRMP #Match2026 #SOAP2026 #NRMP #Matchday #residencymatch

English
3
0
15
6.6K
Omar Alkasabrah, MD
Omar Alkasabrah, MD@alkasabrah·
Honored to contribute to this interesting study. Active IBD = higher influenza risk and worse outcomes. Important data for our patients.
Mohamed Eldesouki, MD@Eldesouki_mo

🔔 New paper alert 🔔 Our study in @DDS_Journal demonstrates that patients with active #IBD have higher risk of influenza and worse outcomes compared to those in remission. Highest risk observed with steroids, JAK inhibitors, & anti-IL-23 therapies. Grateful for the mentorship of @JHashashMD and @FarrayeIBD, and to my coauthors @alkasabrah @AlsakarnehSaqr & @Youssefmd96 pubmed.ncbi.nlm.nih.gov/41790400/

English
0
1
2
532
Omar Alkasabrah, MD retweetledi
Mohamed Eldesouki, MD
Mohamed Eldesouki, MD@Eldesouki_mo·
For the third year in a row, we’re presenting at #DDW, and this year at #DDW2026 feels extra special: 2 Oral Presentations with my incredible mentors Dr Shaukat, Dr Farraye, and Dr Hashash 🙌 Can’t wait to see you all in Chicago!! @AasmaShaukatMD @FarrayeIBD @JHashashMD
Mohamed Eldesouki, MD tweet media
English
9
7
64
4.8K
Omar Alkasabrah, MD
Omar Alkasabrah, MD@alkasabrah·
@MahmoudTablawy1 قدر الله وما شاء فعل. صحيح انه ال elective بزيد فرصك بالماتش. بس عن تجربة وبعرف ناس كثيرة متشت بدون الكتف. اعتقد انك لسا fresh graduate، ليش ما تقدم عالماتش عطول. ال J visa عادة اسهل ال B1/B2
العربية
0
0
3
722
Conrad Fischer
Conrad Fischer@SeeFisch·
MRSA skin abscesses TMP/SMZ is better because it is a TWICE a day drug and clindamycin is a THREE time a day drug. Better than doxycycline too, because TMP/SMZ is more "Bactericidal" not "Static" Linezolid is great, but causes: *Lactic acidosis *Thrombocytopenia *Interacts with MAO inhibitors
English
7
26
246
21.9K
Mohamed Eldesouki, MD
Mohamed Eldesouki, MD@Eldesouki_mo·
🚨 Publication Alert 🚨 🌟 Started as DDW2025 oral presentation ➡️ now a published manuscript in Journal of Clinical Gastroenterology @JCGjournal 📘✨Really love this cycle 🔁🔥 👉🏼 Our study compares the safety of endoscopic vs radiologic gastrostomy tube placement 📌 PEG was associated with fewer complications compared with IR-guided gastrostomy ⬇️ 🙏 Beyond grateful for Dr @SherifElhanafi for the incredible support, and guidance throughout this process 🌟✨🤍 @ElfertKhaled journals.lww.com/jcge/abstract/…
English
7
5
60
6.1K
Saqr Alsakarneh, MD, MS
Saqr Alsakarneh, MD, MS@AlsakarnehSaqr·
New publication 🚨 Small bowel Crohn’s disease is sometimes hard to treat 😮 and biologic agents positioning is not clear ✋🏻 In this study we showed that 🎯Anti-interlukins (UST/RZA) maybe preferred over Vedolizumab for SB Crohn’s. 📖: academic.oup.com/ibdjournal/adv… #GITwitter
English
2
9
67
5.6K
Omar Al Ta'ani
Omar Al Ta'ani@OmarAlTaanii·
Very excited to share that I will be pursuing my GI fellowship at @WashUMedGastro! Grateful every day for the incredible support from my family, friends, and mentors who made this possible. Looking forward to the journey ahead! 🎉 @AHNIMres @TKapetanos
WashU Medicine Department of Medicine@WashUDeptMed

Welcome to Match Day 2026! ⁠ ⁠ We would like to offer a sincere #WashUDeptMed welcome to our newly matched 2026 fellows for the Department of Medicine @WashUMedGastro ⁠ We welcome to WashU Medicine and wish you all much success! #MATCHDAY

English
20
5
108
12.7K
Ahmed E Salem
Ahmed E Salem@DrAhmedSalem2·
✨ Some dreams take years. Some take a village. 🤍 Today both came true. 🙏🌱 🩺 I matched in Gastroenterology at @CleveClinicFL 🎉🏥 🌟 Special thanks to my compass 🧭, my mentor🧭@Alomari_MD your guidance changed everything ❤️ 🤍 Grateful beyond words to every mentor 🤝✨❤️
Ahmed E Salem tweet mediaAhmed E Salem tweet mediaAhmed E Salem tweet media
English
48
13
297
23.7K
Mohamed Eldesouki, MD
Mohamed Eldesouki, MD@Eldesouki_mo·
⚠️ Publication Alert ⚠️ Very excited to see our paper published in Digestive Diseases and Sciences @DDS_Journal after receiving an award at ACG 2025! Thank you, Dr @AasmaShaukatMD for your guidance, and wonderful mentorship! doi.org/10.1007/s10620…
Mohamed Eldesouki, MD@Eldesouki_mo

🌟🌟 Delighted to receive ACG Presidential Poster Award for our work about the trends and disparities of CRC screening at #ACG2025 Grateful for the great mentorship and support of Dr @AasmaShaukatMD 🙏🙏 @AmCollegeGastro

English
6
4
42
11.2K
Mohamed Elnaggar
Mohamed Elnaggar@MelnaggarM·
🚨 From ACG abstract to full paper, Key insights on Emphysematous Gastritis (EG): 📊 Comprehensive review of 116 EG cases 🖥️ CT imaging = most effective, showing 95% sensitivity for detecting intramural gas 💊 70% recovered with medical therapy alone (antibiotics + supportive care) 🦠 Sarcina ventriculi identified as the most common gas-forming organism 📉 Early intervention saves lives mortality now 15% vs. historical 60% A rare disease, but real progress. 🔬 doi.org/10.1016/j.clin… #MedTwitter #Gastroenterology #ACG #GITwitter #EmphysematousGastritis
Mohamed Elnaggar tweet media
English
1
0
9
1.3K

Keşfet

@Eldesouki_mo @FrontImmunol @ENSP_mayo @MayoClinicGIHep @BeyderLab @APandT @AmolSharmaMD @ElfertKhaled